Survival benefit of adjuvant chemotherapy after resection of Stage I lung adenocarcinoma containing micropapillary components

ConclusionAmong patients with stage I lung adenocarcinoma with MIP components, those who received ACT showed significant survival benefits compared to those without ACT. Patients with lung adenocarcinoma with MIP components could benefit from ACT when the MIP was ≥1%.

Source: Cancer Medicine - February 24, 2024 Category: Cancer & Oncology Authors: Ying Li, Junfeng Zhao, Ying Zhao, Ruyue Li, Xue Dong, Xiujing Yao, Zhongshuo Xia, Yali Xu, Yintao Li Tags: RESEARCH ARTICLE Source Type: research